/

Contineum Therapeutics

Developing oral therapies for neurological and inflammatory diseases.

BiotechnologyPharmaceuticals contineum-tx.com ↗

Company facts

Founded: 2017
Employees: 41
Headquarters: United States
Type: Public
Listed: NASDAQ: CTNM